{"filing":{"accession_number":"0001213900-26-088341","cik":"0001833498","ticker":"MDAIW","company_name":"Spectral AI, Inc.","form":"8-K","filing_date":"2026-08-12","report_date":"2026-08-11","primary_document":"ea0301807-8k_spectral.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1833498/000121390026088341/ea0301807-8k_spectral.htm"},"events":[{"id":27146,"run_id":24722,"accession_number":"0001213900-26-088341","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses Spectral AI's financial results for Q2 2026 (quarter ended June 30, 2026), including revenue of $3.5 million, net loss of $(4.2) million, and cash position of $14.0 million. The press release (Exhibit 99.1) provides a comprehensive earnings announcement with detailed financial metrics, business highlights including FDA clearance for the DeepView System, and forward guidance of $18.5 million revenue for 2026. This is a standard quarterly earnings release disclosed via Item 2.02 and Item 7.01.","company_name":"Spectral AI, Inc.","ticker":"MDAIW","filing_date":"2026-08-12","form":"8-K","submitted_at":null,"items":[{"id":28548,"accession_number":"0001213900-26-088341","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses Spectral AI's financial results for Q2 2026 (quarter ended June 30, 2026), including revenue of $3.5 million, net loss of $(4.2) million, and cash position of $14.0 million. The press release (Exhibit 99.1) provides a comprehensive earnings announcement with detailed financial metrics, business highlights including FDA clearance for the DeepView System, and forward guidance of $18.5 million revenue for 2026. This is a standard quarterly earnings release disclosed via Item 2.02 and Item 7.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T20:05:21.375459+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28548,"accession_number":"0001213900-26-088341","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses Spectral AI's financial results for Q2 2026 (quarter ended June 30, 2026), including revenue of $3.5 million, net loss of $(4.2) million, and cash position of $14.0 million. The press release (Exhibit 99.1) provides a comprehensive earnings announcement with detailed financial metrics, business highlights including FDA clearance for the DeepView System, and forward guidance of $18.5 million revenue for 2026. This is a standard quarterly earnings release disclosed via Item 2.02 and Item 7.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T20:05:21.375459+00:00","company_name":"Spectral AI, Inc.","ticker":"MDAIW","filing_date":"2026-08-12"}]}